ORLANDO, Florida, June 23, 2018 /PRNewswire/ --
Adults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in HbA1c and a
Growth Capitalist (https://growthcapitalist.com/2018/06/tresiba-demonstrated-significantly-improved-blood-sugar-control-and-lower-rates-of-hypoglycaemia-versus-insulin-glargine-u300-in-real-world-evidence-study/)
ORLANDO, Florida, June 23, 2018 /PRNewswire/ --
Adults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in HbA1c and a